netFormulary NHS
South Staffordshire Joint Formulary
Cannock Chase Clinical Commissioning Group
East Staffordshire Clinical Commissioning Group
South East Staffordshire and Seisdon Peninsula Clinical Commissioning Group
Stafford and Surrounds Clinical Commissioning Group
 Search
 Formulary Chapter 3: Respiratory system - Full Chapter
Chapter Links...
 Details...
03.01.02  Expand sub section  Antimuscarinic bronchodilators
Ipratropium Bromide
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Ipratropium Bromide Inhalation Solution 500mcg/2ml Ud
Ipratropium Bromide Inhalation 20mcg (200 D) CFF 
 
 

 
   
Tiotropium (Spiriva Respimat®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Spiriva Respimat® 2.5microgam/dose inhalation solution device 
 
Long-Acting Antimuscarinic 
 
Green Traffic Light  COPD ONLY


Amber E  FOR ASTHMA must be initiated by specialist then transferred to primary care using the RICaD within the asthma guidlelines
 

 
Link  Tiotropium respimat vs handihaler no significant difference in mortality in TIOSPIR trial
   
Glycopyrronium Bromide (Seebri breezhaler®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green
Glycopyrronium Bromide Inhalation Capsule 55mcg + Device
Seebri Breezhaler 44mcg Inhalation Powder Capsules + Device

Long-Acting Antimuscarinic
Indication for COPD ONLY.

 
Link  NICE ESNM9: Chronic obstructive pulmonary disease: Glycopyrronium Bromide
   
Tiotropium with olodaterol (Spiolto Respimat®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Olodaterol (as Olodaterol hydrochloride 2.5microgram per 1 dose, Tiotropium (as Tiotropium bromide) 2.5 microgram per 1 dose, solution for inhalation cartridge with device (60 dose).

 
   
Umeclidinium Bromide (Incruse Ellipta)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green
Umeclidinium Bromide 65mcg/dose DPI
Incruse Ellipta 55mcg/dose DPI

Long-Acting Antimuscarinic
Indication for COPD ONLY.


 
Link  NICE ESNM52: Chronic obstructive pulmonary disease: umeclidinium inhaler (Incruse)
   
Aclidinium Bomide (Eklira Genuair®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green
Aclidinium Bomide 375mcg/dose Dry Powder Inhaler
Eklira 322mcg/dose Genuair Inhalation Powder

Long Acting Antimuscarinic
Indication for COPD ONLY.


NOTE: This is a twice daily preparation therefore not suitable for all patients. 
Link  NICE ESNM8: Chronic obstructive pulmonary disease: aclidinium bromide
   
 ....
 Non Formulary Items
Ipratropium Bromide  (Ipratropium Steri-Neb®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Ipratropium Bromide  (Respontin®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Tiotropium  (Tiotropium Handihaler ®)

View adult BNF View SPC online View childrens BNF Track Changes
Non Formulary The handihaler device is non formulary please prescribe the respimat or one of the other formulary LAMAS

 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Drugs which require special consideration. These are drugs for Consultant Prescribing ONLY. They should not be prescribed in Primary Care.  

Amber

Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care. For some drugs there may be a Ricad in place to aid the transition to primary care.  

Amber E

Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care but also require and ESCA (Shared Care Agreement)   

Green

Suitable first-line drugs for implementation in Primary Care  

On Formulary

South Staffs Formulary Choice  

netFormulary